Daiichi: Ranbaxy offer oversubscribed

Daiichi Sankyo Co said on Wednesday its open offer to buy up to 20 % of generic drugmaker Ranbaxy Laboratories Ltd was oversubscribed.

Daiichi firm on Ranbaxy buyout despite US FDA action

Daiichi defers open offer for Ranbaxy’s additional 20%

Daiichi Sankyo acquires 20% of Ranbaxy

Ranbaxy open offer subscribed over 2 times

Govt approves Daiichi-Ranbaxy deal

This entry was posted on Wednesday, September 24th, 2008 at 10:29 am and is filed under Pharma. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Indian Stock Market

Daiichi: Ranbaxy offer oversubscribed

Leave a Reply

Categories

Archives

Feed

Links

Subscribe by E-Mail :

Recent Posts

Recent Comments

Indian Stock Market News